Leukemia Clinical Trials

Showing 141-160 of 9,450 trials

A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer

NCT07538804

This is a first-in-human (FIH) Phase I/II, multi-center, open-label, study of ANS02, in patients with advanced NSCLC. The study evaluates the safety, tolerability, preliminary efficay, pharmacokinetics, anti-tumor activity of ANS02 as monotherapy.

Non-Small Cell Lung Cancer

Avistone Biotechnology Co., Ltd.294 participantsStarted Jun 2026

Fairfax, Virginia, United States • Guangzhou, Guangdong, China • Harbin, Heilongjiang, China +1 more locations

RECRUITINGPhase 4

Dabrafenib and/or Trametinib Rollover Study

NCT03340506

This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-sponsored study who have fulfilled the requirements for the primary objective, and who are judged by the investigator as benefiting from continued treatment in the parent study as judged by the Investigator at the completion of the parent study.

MelanomaNon Small Cell Lung CancerSolid Tumor+2 more

Novartis Pharmaceuticals100 participantsStarted Dec 2017

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • Bethesda, Maryland, United States +25 more locations

A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer

Dabrafenib and/or Trametinib Rollover Study

Related Searches

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

CAR T-cell Therapy in Patients With Renal Dysfunction

NEUROATHLETIC AND REACTIVE TRAINING IN AMERICAN FOOTBALL PLAYERS

A Prospective, Controlled, Single-Center Confirmatory Study to Evaluate the Accuracy and Safety of Core Temperature Measurement Using the XST600 Electronic Thermometer Compared to the 3M SpotOn Thermometer in Adult Patients

Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Baricitinib for Post-HSCT Persistent Thrombocytopenia

A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma